工程CAR-T疗法用于增强固体瘤向
Danqing Zhu1,2, Won Joon Kim1, Hyunjin Lee3
1Department of Chemical and Biological Engineering, School of Engineering, The Hong Kong University of Science and Technology (HKUST), Kowloon, Hong Kong SAR, 999077, China.
Advanced materials (Deerfield Beach, Fla.)
|January 2, 2025
概括
化学抗原受体 (CAR) -T细胞疗法通过提高T细胞的特异性和克服瘤微环境挑战,对固体瘤显示出前景. 新的工程策略和验证平台是推动CAR-T疗法的关键,以改善癌症治疗.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
背景情况:
- 化学抗原受体 (CAR) -T细胞疗法是癌症免疫疗法的突破,特别有效于对抗血液性恶性瘤.
- 然而,由于抗原异质性和复杂的瘤微环境 (TME) 等挑战,其在构成绝大多数癌症的固体瘤中的有效性仍然有限.
研究的目的:
- 本综述探讨了创新的策略,以加强对固体瘤的CAR-T细胞疗法.
- 它的重点是提高T细胞的特异性,解决分娩和体内重编程的挑战,并探索先进的验证平台.
主要方法:
- 探索实验和计算策略,包括蛋白质工程和机器学习,以提高T细胞的特异性.
- 对固体瘤的T细胞输送和体内重编程技术的讨论.
- 研究工程有机体系统作为TME的高保真体外模型,用于CAR发现和验证.
主要成果:
- 最近的临床试验显示,像神经母细胞瘤和胃肠道癌等固体瘤对CAR-T治疗有一定的反应性.
- 工程器官系统正在成为模仿TME和验证CAR设计的强大工具.
- 在CAR设计和验证平台的进步对于克服固体瘤挑战至关重要.
结论:
- 创新的工程策略具有显著的潜力,可以增强对固体瘤的CAR-T细胞治疗.
- 这些进展旨在彻底改变下一代CAR-T疗法,从而为更广泛的癌症提供更有效的治疗方法.
- 克服TME复杂性和改善T细胞向对于未来的成功至关重要.
更多相关视频
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
470
08:46A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
Published on: November 12, 2019
53.2K
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:27Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K